Vitamin K Deficiency Bleeding

Vitamin K Deficiency Bleeding: What New Studies Say About Missed Newborn Shots and Rising Infant Bleeding

Soft painted illustration of an empty hospital nursery bassinet with a folded knit blanket, beside a window with gentle morning light
Illustration (AI-generated)

A rare but potentially life-threatening condition in babies, vitamin K deficiency bleeding, is getting renewed attention this week. Two large U.S. studies, published Nov. 5 in JAMA and JAMA Pediatrics, found that more newborns are going without the routine vitamin K shot given at birth, and that recorded infant bleeding has risen over the same period.

The research drew fresh coverage Tuesday, Nov. 10, including an Axios report on the findings. Here is what the condition is and what the studies do and don’t show.

This article summarizes published research and news reports. It is not medical advice. Parents with questions about newborn care should talk with their doctor or pediatrician.

What is vitamin K deficiency bleeding?

Vitamin K is a nutrient the body needs for blood to clot. Babies are born with naturally low levels, according to Children’s Hospital of Philadelphia (CHOP), so some may not clot effectively. Vitamin K deficiency bleeding, often shortened to VKDB, is the bleeding that can result. CHOP describes it as rare but potentially life-threatening, and notes it can include bleeding in or around the brain.

A one-time vitamin K injection at birth has been standard care in the U.S. since 1961, according to Reuters and Axios. Axios noted that the shot is a vitamin, not a vaccine.

What did the new studies find?

The JAMA study (CHOP). Researchers analyzed health records for about 5.2 million infants born from 2017 through 2025 in all 50 states and Washington, D.C. Key findings, per CHOP:

  • The share of newborns without a documented vitamin K shot more than doubled, from 3.1% in 2017 to 6.8% in 2025.
  • Babies without documented vitamin K had 288 recorded bleeding events per 10,000 births in their first six months, compared with 186 per 10,000 among babies who got the shot. After adjusting for other factors, that was a 47% higher risk.
  • Bleeding in or around the brain occurred in 33 per 10,000 births without the shot versus 13 per 10,000 with it, more than double the risk.
  • Death during the birth hospitalization with a bleeding diagnosis was also more common among infants without documented vitamin K.
  • The researchers estimated one additional bleeding event for roughly every 114 newborns who don’t receive the shot.

The JAMA Pediatrics study (Virginia Commonwealth University). This team examined records for about 11 million infants ages six months and younger from 2017 to 2025. According to Reuters, the share of newborns getting the shot fell from 97.7% to 95%. Axios reported that the diagnosis rate for vitamin K deficiency bleeding rose from 24 to 107 per 100,000 infants. Reuters described this as nearly quadrupling, and Axios as more than quadrupling. Lead researcher Dr. Steven Woolf told Reuters that “the rate in 2025 was approximately double what it was in 2024.”

Do the studies prove the missed shots caused the bleeding?

No. Woolf told Reuters the studies do not prove causation, but said the parallel rise in refusals and bleeding is significant. Axios noted that neither study gave state-by-state rates or determined why individual babies missed the shot. Bleeding remained uncommon overall.

Why are fewer babies getting the shot?

The studies did not measure parents’ reasons. Reuters reported that refusals have risen since the COVID-19 pandemic and have accelerated amid growing mistrust of vaccines and other newborn interventions. It reported that health experts point to mixed public health messaging under Health Secretary Robert F. Kennedy Jr., who has dropped childhood recommendations for six vaccines, a change now on hold because of a legal challenge.

Axios reported that misinformation about the shot’s safety circulates on social media. In JAMA Pediatrics, researchers suggested the shot may be a “victim of its own success,” with the condition now so rare that parents may underestimate the risk.

A Department of Health and Human Services spokesperson told Reuters that the CDC still recommends vitamin K shots for newborns. The spokesperson declined to say whether the agency would begin tracking refusals or bleeding events, which the CDC does not currently do.

What are doctors saying?

“Routine intramuscular vitamin K administration has been highly effective at preventing vitamin K deficiency bleeding in newborns for decades,” said Dr. Heather Burris, a CHOP neonatologist and study co-author. She told Axios that getting the shot is like wearing a seat belt: a simple precaution against an unlikely but potentially devastating outcome.

Dr. Elizabeth Wolf of Children’s Hospital of Richmond, who led the VCU study, told Reuters the findings call for clear public health messaging about vitamin K.

What’s next

Reuters reported that in June, Rep. Kim Schrier of Washington and Sen. Angela Alsobrooks of Maryland, both Democrats, asked the CDC to start tracking these bleeding events. Axios reported that doctors are also watching whether hesitancy spreads to other routine newborn shots, including the hepatitis B vaccine.

Related topics: vitamin K shot, newborn vitamin K, VKDB, vitamin K refusal.

Sources